4.7 Review

NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration

Journal

CELL PROLIFERATION
Volume 54, Issue 7, Pages -

Publisher

WILEY
DOI: 10.1111/cpr.13057

Keywords

intervertebral disc degeneration; nuclear factor‐ κ B; nucleus pulposus

Categories

Funding

  1. special fund project for doctoral training program of Lanzhou University Second Hospital [YJS-BD-09]
  2. Lanzhou University Innovation and Entrepreneurship Cultivation Project [cxcy201906]
  3. Chinese Medicine Administration Research Project of Gansu province [GZK-2019-46]
  4. Cuiying Technology Innovation Project of Lanzhou University Second Hospital [CY2019-MS10]

Ask authors/readers for more resources

NF-κB is considered a pathogenic factor of intervertebral disc degeneration (IDD), studying its role and regulatory mechanism in IDD pathology can help in developing targeted therapeutic strategies to reduce potential risks.
Intervertebral disc degeneration (IDD) is a common clinical degenerative disease of the spine. A series of factors, such as inflammation, oxidative stress and mechanical stress, promote degradation of the extracellular matrix (ECM) of the intervertebral discs (IVD), leading to dysfunction and structural destruction of the IVD. Nuclear factor-kappa B (NF-kappa B) transcription factor has long been regarded as a pathogenic factor of IDD. Therefore, NF-kappa B may be an ideal therapeutic target for IDD. As NF-kappa B is a multifunctional functional transcription factor with roles in a variety of biological processes, a comprehensive understanding of the function and regulatory mechanism of NF-kappa B in IDD pathology will be useful for the development of targeted therapeutic strategies for IDD, which can prevent the progression of IDD and reduce potential risks. This review discusses the role of the NF-kappa B signalling pathway in the nucleus pulposus (NP) in the process of IDD to understand pathological NP degeneration further and provide potential therapeutic targets that may interfere with NF-kappa B signalling for IDD therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available